DJIA 18,132.70 -81.72 -0.45%
NASDAQ 4,963.53 -24.36 -0.49%
S&P 500 2,104.50 -6.24 -0.30%
market minute promo

1.25 0.30 (31.72%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

AVEO $1.25 31.72%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.95
Previous Close $0.95
Daily Range $0.95 - $1.29
52-Week Range $0.61 - $1.96
Market Cap $65.3M
P/E Ratio -0.89
Dividend (Yield) $0.00 (0.0%)
Volume 3,704,090
Average Daily Volume 240,777
Current FY EPS -$1.12

Sector

Healthcare

Industry

Drug Makers

AVEO Pharmaceuticals, Inc. (AVEO) Description

AVEO Pharmaceuticals Inc. is a biopharmaceutical company. It is engaged in discovering developing and commercializing novel cancer therapeutics. Website: http://www.aveooncology.com/

News & Commentary Rss Feed

Mid-cap Biotechs are the Best Bet

Mid-cap biotechs have greatly outperformed their peers.

Seeking Baupost: The Pangs Of Value Investing - Part 1

CAR-T Vs ErbB3 Market Opportunity Comparison

US Stock Futures Surge Ahead Of ADP Report, Fed Minutes

The New Baupost Biotech Picks

AVEO Gains on Tivozanib Agreement with Ophthotech - Analyst Blog

US Stock Futures Slightly Higher; Dollar Surges Against Yen

AVEO Enters into Research And Exclusive Option Agreement With Ophthotech For Tivozanib (VEGF inhibit

AVEO Enters into Research And Exclusive Option Agreement With Ophthotech For Tivozanib (VEGF inhibitor) For The Treatment Of Ocular Diseases

Will AVEO Pharmaceuticals (AVEO) Surprise this Earnings? - Analyst Blog

Leon Cooperman To Cash In On Atlas Energy Acquisition

AVEO-Biodesix Reveal Lung Cancer Study Exploratory Data - Analyst Blog

AVEO-Biodesix Reveal Lung Cancer Study Exploratory Data - Analyst Blog

See More AVEO News...

AVEO's Top Competitors

AVEO $1.25 (31.72%)
Current stock: AVEO
AMGN $157.72 (-0.79%)
Current stock: AMGN
GILD $103.53 (-0.63%)
Current stock: GILD
BIIB $409.59 (-0.12%)
Current stock: BIIB